KR20170022343A - Prevention, improvement of skin allergy agent based on lactic acid, floral water and medicinal herb extract - Google Patents
Prevention, improvement of skin allergy agent based on lactic acid, floral water and medicinal herb extract Download PDFInfo
- Publication number
- KR20170022343A KR20170022343A KR1020150117174A KR20150117174A KR20170022343A KR 20170022343 A KR20170022343 A KR 20170022343A KR 1020150117174 A KR1020150117174 A KR 1020150117174A KR 20150117174 A KR20150117174 A KR 20150117174A KR 20170022343 A KR20170022343 A KR 20170022343A
- Authority
- KR
- South Korea
- Prior art keywords
- lactic acid
- skin
- floral water
- extract
- lactobacillus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 46
- 239000000284 extract Substances 0.000 title claims abstract description 45
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims description 66
- 235000014655 lactic acid Nutrition 0.000 title claims description 33
- 239000004310 lactic acid Substances 0.000 title claims description 33
- 239000003795 chemical substances by application Substances 0.000 title abstract description 14
- 201000004624 Dermatitis Diseases 0.000 title abstract description 6
- 230000002265 prevention Effects 0.000 title description 3
- 241000186660 Lactobacillus Species 0.000 claims abstract description 12
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 9
- 241000196324 Embryophyta Species 0.000 claims abstract description 8
- 238000000855 fermentation Methods 0.000 claims description 33
- 230000004151 fermentation Effects 0.000 claims description 33
- 241000894006 Bacteria Species 0.000 claims description 18
- 241000411851 herbal medicine Species 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 8
- 244000178870 Lavandula angustifolia Species 0.000 claims description 7
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 7
- 239000001102 lavandula vera Substances 0.000 claims description 7
- 235000018219 lavender Nutrition 0.000 claims description 7
- 244000269722 Thea sinensis Species 0.000 claims description 5
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims description 4
- 235000003880 Calendula Nutrition 0.000 claims description 4
- 240000001432 Calendula officinalis Species 0.000 claims description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 235000009569 green tea Nutrition 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 2
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 2
- 239000005862 Whey Substances 0.000 claims description 2
- 102000007544 Whey Proteins Human genes 0.000 claims description 2
- 108010046377 Whey Proteins Proteins 0.000 claims description 2
- 235000021329 brown rice Nutrition 0.000 claims description 2
- 229940106189 ceramide Drugs 0.000 claims description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 2
- 229910052956 cinnabar Inorganic materials 0.000 claims 2
- 241000223782 Ciliophora Species 0.000 claims 1
- 235000006679 Mentha X verticillata Nutrition 0.000 claims 1
- 235000002899 Mentha suaveolens Nutrition 0.000 claims 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims 1
- 241000186429 Propionibacterium Species 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
- 239000000043 antiallergic agent Substances 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 8
- 244000005700 microbiome Species 0.000 abstract description 4
- 241001122767 Theaceae Species 0.000 abstract 1
- 239000003908 antipruritic agent Substances 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 206010003645 Atopy Diseases 0.000 description 29
- 235000010633 broth Nutrition 0.000 description 28
- 208000024891 symptom Diseases 0.000 description 25
- 238000002360 preparation method Methods 0.000 description 20
- 208000003251 Pruritus Diseases 0.000 description 16
- 239000007788 liquid Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 206010012438 Dermatitis atopic Diseases 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 7
- 201000008937 atopic dermatitis Diseases 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000002874 Acne Vulgaris Diseases 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 206010000496 acne Diseases 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241001521757 Propionibacterium sp. Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- -1 ascorbic acid ester Chemical class 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000012676 herbal extract Substances 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VOJUXHHACRXLTD-UHFFFAOYSA-N 1,4-dihydroxy-2-naphthoic acid Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CC(O)=C21 VOJUXHHACRXLTD-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 241000238711 Pyroglyphidae Species 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000012364 cultivation method Methods 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229940046533 house dust mites Drugs 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000020712 soy bean extract Nutrition 0.000 description 2
- 239000012855 volatile organic compound Substances 0.000 description 2
- VOJUXHHACRXLTD-UHFFFAOYSA-M 1,4-dihydroxy-2-naphthoate Chemical compound C1=CC=C2C(O)=CC(C([O-])=O)=C(O)C2=C1 VOJUXHHACRXLTD-UHFFFAOYSA-M 0.000 description 1
- 108010065780 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase Proteins 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical class N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 241000723345 Chrysophyllum Species 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241000186610 Lactobacillus sp. Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000237986 Melia azadirachta Species 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241001171103 Propionimicrobium Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000002248 Setaria viridis Nutrition 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000194022 Streptococcus sp. Species 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 238000000222 aromatherapy Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229940059958 centella asiatica extract Drugs 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000009151 chronic rhinitis Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002844 continuous effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 108010089355 dihydroneopterin aldolase Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000002878 effect on pruritus Effects 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 244000230342 green foxtail Species 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 229940035429 isobutyl alcohol Drugs 0.000 description 1
- 229940089442 lacticare Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
본 발명은 유산균 발효액, 플로랄 워터 및 생약 추출물을 기반으로 하는 소양증, 피부 트러블과 같은 각종 피부 알레르기의 예방·개선제에 관한 것이다.The present invention relates to a prophylactic and / or ameliorative agent for various skin allergies such as pruritus and skin troubles based on lactic acid fermentation broth, floral water and herbal medicine extract.
근년, 음식물, 각종 가로수나 꽃 등의 특정 화분, 집 먼지, 집 진드기, 화학물질 등에 의한 아토피성 피부염 등의 피부 소양증, 피부 질환, 알레르기 증상이 사회 문제로 되어 있다. In recent years, skin pruritus such as food, various pollen of various trees and flowers, house dust, house dust mites, atopic dermatitis caused by chemical substances, skin diseases and allergic symptoms are social problems.
특히, 주택의 높은 기밀화와 함께, 시공시의 포름알데히드, 톨루엔 등의 휘발성 유기 화합물의 사용, 애완동물의 실내 사육, 이불이나 요에 사람의 피부 각질, 비듬 등의 물질로 인한 집 진드기의 번식, 냉난방의 연속 사용에 의해, 진드기, 그 사체나 분말, 곰팡이, 화분, 애완동물의 털 등의 집 먼지나 휘발성 유기 화합물 등의 화학물질 등이 실내에 장기간 체류하여, 각종 알레르기 증상을 일으키는 것이 문제로 되고 있다.Particularly, with the high airtightness of houses, use of volatile organic compounds such as formaldehyde and toluene at the time of construction, indoor breeding of pets, breeding of house dust mites caused by substances such as skin keratin and dandruff , Continuous use of air conditioning and heating causes house dusts such as ticks, carcasses, powder, mold, pollen, pet hair, and chemical substances such as volatile organic compounds to stay in the room for a long time and cause various allergic symptoms .
통상, 소양증, 피부 트러블이나 알레르기 증상의 치료에 내복약으로서는 항히스타민제나 항알레르기제 등이 주로 사용되며, 외용제로는 항히스타민제, 부신피질 스테로이드제, 비스테로이계 항소염제, 오피오이드 κ 수용체 작동성 화합물 등의 약제를 사용하고 있으나, 내복약의 경우 작용 발현까지의 시간이 오래 걸리며, 복용 후 졸리거나 권태감 등의 중추신경 억제 작용, 소화기계 장해 등의 부작용이 크고, 외용제의 경우 소양증이나, 피부 트러블의 개선 효과가 만족스럽지 못하고, 장기간 사용시 부신 기능 저하 등의 부작용이 문제로 되고 있다. In general, antihistamines and antiallergic agents are mainly used for the treatment of pruritus, skin troubles and allergic symptoms. Examples of the external preparations include antihistamines, adrenocorticosteroids, bisteronyl anti-inflammatory agents and opioid κ receptor-activating compounds Although medicines are used, the time required for the internal medicine to take time is long, and side effects such as the depression of the central nervous system such as sleepiness and fatigue after taking the medicine are great, side effects such as digestive system trouble are large, And adverse side effects such as deterioration of adrenal function during long-term use have become a problem.
전술한 부작용의 해결이나, 상기 증상들의 경감에 지속적 효과가 거의 없기 때문에, 비교적 간편하게 안전성이 높은 식품 유래의 액제나 연고제를 사용하여 소양증, 피부 트러블이나 알레르기 증상 등을 예방하거나, 개선, 치료하고자 하는 것이 요망되고 있다.There is almost no continuous effect in solving the aforementioned side effects and the relief of the above symptoms. Therefore, it is possible to use a liquid or ointment derived from a food which is relatively easily safe, to prevent, ameliorate or treat pruritus, skin trouble or allergy symptoms Is desired.
예를 들면, 감잎 엑기스가 피부 트러블이나 아토피성 피부염 모델에서의 유효성이 확인되고 있다(특허 문헌 1). 알레르기 증상을 경감할 수 있는 식품이나 안전성이 높은 천연 미생물 등에 대하여는 아직까지 그의 확실한 유효성이 알려진 것은 그리 많지 않고, 다만 유산균이나 그의 발효액이 종래부터 음식물 제조에 이용되고 있고, 또 이들 배양액 중에 1,4-디히드록시-2-나프토산(DHNA)이 포함되어 있는 것이 보고되고 있으며(특허 문헌 2), 유제품의 단백질 분해효소 처리물을 함유하는 배지를 이용하여 프로피오니박테리움·프로이덴라이히 ET-3주를 배양한 배양액을 유효성분으로 하는 피부거침 예방·개선제가 알려져 있다(특허문헌 3). 그러나 피부 트러블이나 알레르기 증상은 음식물의 섭취에 의해 단시간에 그의 개선 효과는 기대하기 어렵고, 특히 소양증에 대한 효과는 거의 기대할 수 없다. For example, persimmon leaf extract has been confirmed to be effective in skin troubles and atopic dermatitis models (Patent Document 1). There is not so much known for its effective efficacy for foods that can alleviate allergic symptoms or for highly safe natural microorganisms. However, lactic acid bacteria and their fermentation broths have conventionally been used in the manufacture of foods, and 1,4 -Dihydroxy-2-naphthoic acid (DHNA) has been reported (Patent Document 2), and the use of a culture medium containing proteolytic enzyme-treated products of dairy products in the presence of propionibacterium- There has been known a skin roughness prevention / remedy comprising as an active ingredient a culture solution which has been cultured for 3 weeks (Patent Document 3). However, the symptoms of skin troubles and allergies can not be expected to improve in a short time due to ingestion of food, and the effect on pruritus can hardly be expected.
상기 문제를 개선하기 위하여 비교적 부작용이 적은 종래부터 사용되어온 한방 약재, 소위 생약 성분을 이용하는 것에 관련 특허출원이 다수 확인된다. 천연 혼합물인 백급 등과 발효대두 추출물을 물, 또는 유기용매로 추출하고, 이를 여과하여 얻은 추출액이 항균효과, 항염증 효과, 아토피 치유 개선효과가 있다고 보고하고 있다(특허문헌 4). 이 특허문헌을 보면 생약 성분과 발효대두 추출물을 추출함에 있어서, 물(정제수)이나 에탄올 등의 유기용매로 추출하는 경우, 차이는 거의 없고, 발효 대두의 경우, 어느 정도 발효가 되어 있는지도 기재되어 있지 않아 그의 추출물의 유효성이 어느 정도인지 알 수 없고, 개선 효과를 확인하기 위하여 60일간 도포하는 것은 실질적으로 어느 정도 개선 효과가 있는지 인정하기 어렵고, 아토피 환자가 장기간 도포하여 개선 효과를 얻는 것을 기대하기 어려워 소비자가 만족할 만한 조성물이라고 보기 어렵다, 더욱이 이들 특허내용의 발명이 현실적으로 실현되지 못하고 있는 점이 이를 반증하는 것이라 할 수 있다. 또한, 이와 유사하게 생약 식물을 배지 영양원의 한 성분으로 하여 유산균을 발효한 식품이 감기, 아토피 피부염에 효과가 있다고 하는 보고가 있다(특허문헌 5, 6). 그러나 식물 성분을 유산균과 함께 발효하기 위하여 올리고당 등의 당류와 유산균 또는 효모균을 발효 탱크에 넣고, 3일 또는 30 내지 90일 발효시켜 발효액을 얻는 공정은 제조기간이 지나치게 길어 경제성이 떨어지거나, 이들 발효물의 역가를 산출하기 어려워 최종 생성물의 균일성을 유지하기 힘들뿐 아니라, 아토피 등의 질환에 대해 개선의 항상성도 신뢰하기 어려운 것으로 사료되며, 이러한 이유로 이 발명의 제품이 시장에서 활성화되지 못하는 것으로 사료된다. In order to solve the above-mentioned problem, a number of patent applications related to the use of conventionally used herbal medicine, so-called herbal medicine ingredient, which have relatively few side effects are confirmed. It has been reported that an extract obtained by extracting a natural mixture, such as a white rice flour and a fermented soybean extract with water or an organic solvent and filtering the same, has an antibacterial effect, an anti-inflammatory effect and an improvement in atopic healing (Patent Document 4). According to this patent document, when extracting a herbal medicine ingredient and a fermented soybean extract, there is little difference when extracting with an organic solvent such as water (purified water) or ethanol, and in fermented soybean, how much fermentation has been described It is difficult to know how much the efficacy of the extract is effective, and it is difficult to recognize the degree of improvement in the practical application of 60 days to confirm the improvement effect, and it is difficult to expect that the atopic patient can apply for a long time to obtain the improvement effect It is difficult to say that the composition is satisfactory for consumers, and the fact that the inventions of these patent contents are not realistically can be disproved. Similarly, there is a report that foods prepared by fermenting lactic acid bacteria with herbaceous plants as a component of a nutrient source are effective for cold and atopic dermatitis (Patent Documents 5 and 6). However, in order to ferment plant components together with lactic acid bacteria, saccharides such as oligosaccharides, lactic acid bacteria or yeast are put into a fermentation tank and fermented for 3 days or 30 to 90 days to obtain a fermentation broth, It is difficult to maintain the homogeneity of the final product, and it is considered that the homeostasis of improvement against diseases such as atopy is also unreliable. For this reason, the product of the present invention is not activated in the market .
그 이외에 생약성분으로서 고삼, 백금, 지모, 소엽맥문동, 어성초, 백지 등의 혼합 추출물을 유효성분으로 함유하는 아토피성 피부 등의 피부 트러블 개선용 외용제(화장료 포함)가 다수 보고되어 있다(예, 특허문헌 7 내지 23).In addition, there have been reported many external preparations (including cosmetics) for improving skin troubles such as atopic skin containing, as an active ingredient, a mixed extract of ginseng, platinum, plum, lobule, Literature 7 to 23).
본 발명의 목적은 안전성이 높고, 제조 공정이 단순하고, 그의 제조법이 단기일 내에 제조할 수 있으며, 더욱이 아토피나 소양증, 피부 트러블, 알레르기에 대해 단기일 내에 효과를 발휘하는 액상 제제를 제공하는 것이다.It is an object of the present invention to provide a liquid preparation which is high in safety, simple in manufacturing process, can be produced within a short period of time, and exhibits atopy, pruritus, skin troubles and allergies within a short period of time .
본 발명자들은 소양증, 피부 트러블, 알레르기 증상을 저감할 수 있는 물질을 검토한 결과, 유산균 발효액, 플로랄 워터 및 생약 추출물의 혼합액이 모기 등의 벌레에 물려 생긴 소양증이나 피부염, 진드기 유래 항원에 의한 아토피 같은 피부염, 각종 유해성 화학물질로 인한 아토피 증상 및 피동적 피부 아나필락시스(PCA) 반응을 경감하는 작용을 가지며, 상기 혼합액이 항소양제 및 항알레르기제로서 유용함을 발견하였다. The inventors of the present invention have conducted studies on a substance capable of reducing pruritus, skin troubles and allergy symptoms, and found that a mixture of lactic acid fermentation broth, floral water and herbal extract is effective against pruritus or dermatitis caused by insects such as mosquitoes, Dermatitis, atopic symptoms due to various harmful chemicals, and passive skin anaphylaxis (PCA) reactions, and that the above mixed liquid is useful as an anti-allergic agent and as an anti-allergy agent.
따라서, 본 발명은 유산균 발효액, 플로랄 워터 및 생약 추출물의 혼합액을 유효성분으로 하는 항소양제를 제공하는 것이다.Accordingly, the present invention provides an anticancer agent containing as an active ingredient a mixed solution of lactic acid fermentation broth, floral water and herbal medicine extract.
또, 본 발명은 유산균 발효액, 플로랄 워터 및 생약 추출물의 혼합액을 유효성분으로 하는 항알레르기제를 제공하는 것이다.In addition, the present invention provides an antiallergic agent comprising, as an active ingredient, a mixed liquid of lactic acid fermentation broth, floral water and herbal medicine extract.
본 발명의 유산균 발효액, 플로랄 워터 및 생약 추출물의 혼합액의 유산균 발효액은 종래부터 식품제조에 이용되고 있는 천연 미생물에 의한 발효액이므로, 안전성이 높으며, 또한 플로랄 워터와 생약 추출물은 수백 년~수천 년 한방약재 또는 음용 차로서 이용되어온 식물들의 추출액이므로 인체의 피부에 대해 안전성이 높고, 항소양제 및 항알레르기제로서 유용하다. 또, 당해 발효액은 미생물을 이용하기 위해 대량으로 생산하는 것도 가능하며, 플로랄 워터나 생약 추출물도 대량 생산하는 것도 가능하고, 이들 발효액이나, 추출물을 간단히 시판의 것도 이용하는 것도 가능하다. The lactic acid fermentation broth of the fermented broth of Lactobacillus fermentation broth, floral water and herbal medicine extract of the present invention is a fermentation broth using natural microorganisms conventionally used for food production, so that the safety is high, and the floral water and herbal extracts are used for hundreds to thousands of years Or extracts of plants which have been used as drinking tea, and thus are highly safe against human skin and are useful as anti-allergic agents and as anti-allergic agents. In addition, the fermentation broth can be produced in large quantities to use microorganisms, and it is also possible to mass-produce floral water and herbal medicine extracts, and these fermentation broths and extracts can also be commercially available.
도 1 및 도 2는 본 발명의 제조예 1에서 제조한 액제를 심한 소양증을 동반한 아토피성 여드름 증상이 있는 10대 여학생에게 도포하기 전과 도포 3일 및 도포 2주 후의 상태를 나타내는 사진.
도 3은 본 발명의 제조예 1에서 제조한 액제를 아토피 증상이 있는 30대 주부의 도포하기 전의 팔 부위와 도포 3일 및 도포 2주 후의 상태를 나타내는 사진.
도 4는 목 부위에 아토피 증상이 있는 40대 여성의 도포 전과 도포 2주 후의 상태를 나타내는 사진.
도 5는 손등에 아토피 증상이 있는 30대 남성의 도포 전과 도포 2주 후의 상태를 나타내는 사진.
도 6은 얼굴과 목 부위에 아토피 증상이 있는 30대 여성의 도포 전과 도포 3일 및 도포 2주 후의 상태를 나타내는 사진.
도 7은 손등과 목 부위에 아토피 증상이 있는 40대 여성의 도포 전과 도포 2주 후의 상태를 나타내는 사진.
도 8은 종아리 및 무릎 접히는 부분에 아토피 증상이 있는 30대 여성의 도포 전과 도포 3일 후의 상태를 나타내는 사진. Figs. 1 and 2 are photographs showing the state of the liquid preparation prepared in Preparation Example 1 of the present invention before, during 3 days of application, and 2 weeks after application, to a teenage female student suffering from atopic acne accompanied by severe pruritus.
FIG. 3 is a photograph showing the state of the arm part before application of the 30 th housewife with atopic symptoms, and the state after 3 days of application and 2 weeks after application of the liquid preparation prepared in Production Example 1 of the present invention.
FIG. 4 is a photograph showing the state of a woman in her 40s who had symptoms of atopy on the neck area 2 weeks before application and 2 weeks after application.
FIG. 5 is a photograph showing the state of a male in his thirties with atopic symptoms on the back of his hand before and 2 weeks after application. FIG.
FIG. 6 is a photograph showing the state of a woman in her thirties with atopic symptoms on the face and neck, before application, and 3 days after application and 2 weeks after application.
FIG. 7 is a photograph showing the state of a woman in her 40s with atopic symptoms on the back of her hand and neck, before and 2 weeks after application.
FIG. 8 is a photograph showing the state of a woman in her 30s who has atopic symptoms in the calf and knee folds, before and 3 days after application.
본 발명에서 이용하는 유산균 발효액으로 사용되는 유산균은 락토바실러스속, 스트렙토코쿠스속, 프로피오니박테리움속, 프로피오니시모나스속, 프로피오니페락스속, 프로피오니미크로비움속, 프로피오니비브리오속 등이 있으며, 특히 제한되지 않지만, 락토바실러스 박테리아(Lactobacillus bacteria), 스트렙토코쿠스 써모필러스(Streptococcus thermophilus) 및 락토바실러스 락티스(Lactobacillus lactic)에 속하는 균이 바람직하다. Lactic acid bacteria used in the lactic acid fermentation broth used in the present invention include Lactobacillus sp., Streptococcus sp., Propionibacterium sp., Propionis monacus sp., Propionibacterium sp., Propionimicrobium sp., Propionibacterium sp. , And bacteria belonging to Lactobacillus bacteria, Streptococcus thermophilus, and Lactobacillus lactic are preferable, although not particularly limited thereto.
본 발명의 혼합액 중의 유산균 발효액의 제조과정에서의 배양 공정에 이용하는 배지의 영양원은 종래의 배양공정에서 이용되는 우유 등의 유제품, 펩톤 등을 이용하는 것도 불가능한 것은 아니나, 본 발명의 최종 제품에서의 냄새나 끈적거림, 높은 점도 등 때문에 화장료나, 외용제로서 사용하는데에는 엔드 유저가 거부감을 나타낼 수 있으므로, 본 발명에서는 이들 유제품의 성분을 배양 배지로서 사용하지 않다. 본 발명에서 사용하는 발효 배지 영양원으로는 다시마 추출액, 유청(훼이), 현미 뜨물, 펩톤, 소량의 무기 영양원을 이용하는 것이 바람직하다. 이들 배양 발효물은 30∼37℃에서 6∼12시간 발효시킴으로써 얻어진다. The nutrient source of the culture medium used in the culturing process of the fermentation broth of lactic acid bacteria in the mixed solution of the present invention is not impossible to use dairy products such as milk and peptone used in the conventional culture process, Stickiness, high viscosity, etc., end users may show a sense of rejection when used as cosmetics or external preparations. Therefore, the components of these dairy products are not used as a culture medium. As the fermentation medium nutrient source used in the present invention, it is preferable to use kelp extract, whey, brown rice, peptone and a small amount of an inorganic nutrient source. These cultured fermented products are obtained by fermentation at 30 to 37 ° C for 6 to 12 hours.
본 발명에서 사용하는 발효액을 제조하기 위한, 유산균의 배양 방법은 공지의 각종 호기적 또는 혐기적 배양 방법을 이용할 수가 있지만, 액체 배지에 의한 호기적 또는 혐기적 배양법이 대량 생산의 점에서 바람직하다.Various known aerobic or anaerobic cultivation methods can be used for culturing the lactic acid bacteria for producing the fermentation broth for use in the present invention. Aerobic or anaerobic cultivation methods using a liquid culture medium are preferable from the viewpoint of mass production.
혐기적 배양법에 있어서의 배양중의 배양 온도는 20~40℃가 가능하나, 바람직하기로는 30∼37℃에서 발효시키는 것이다. 또, 이때의 배지 pH는 중성~약산성, 구체적으로는 5.0~8.0으로 조정하는 것이 바람직하고, 배양시간은 특히 한정하지 않으나, 6시간~3일간, 바람직하기로는 6시간 내지 12시간이다. In the anaerobic culture method, the incubation temperature during cultivation is 20 to 40 캜, preferably 30 to 37 캜. The pH of the medium at this time is preferably adjusted to a neutral to slightly acidic, specifically 5.0 to 8.0, and the culture time is not particularly limited, but is 6 hours to 3 days, preferably 6 hours to 12 hours.
본 발명의 유효성분인 유산균 발효액은 상기 배지를 이용하여 상기 배양 방법에 의해 유산균을 배양하여 얻어진 것이며, 유산균 및 배양물의 양쪽을 포함한다. 이때, 얻어진 발효액 1mL중에 유산균이 1×103cfu 내지 1×109cfu 포함되어 있는 것이 바람직하다. The lactic acid fermentation broth, which is an effective ingredient of the present invention, is obtained by culturing the lactic acid bacteria by the culture method using the above-mentioned culture medium, and includes both of the lactic acid bacteria and the culture. At this time, it is preferable that 1 ml of the obtained fermentation broth contains 1 x 10 3 cfu to 1 x 10 9 cfu of lactic acid bacteria.
상기에서 얻어진 유산균 및 그의 발효액을 70∼90℃에서 7분 내지 20분간 가열하여 유산균을 사멸시켜 그의 활성을 정지시킨다. 이렇게 하지 않으면, 최종 또는 스톡 솔루션에서 유산균이 계속하여 번식하여 원하는 최종 제품의 품질을 얻을 수 없거나, 또는 훼손시키고, 나아가 제품이 부패하는 결과로 이어진다. 이렇게 얻어진 유산균 그대로 사용해도 좋지만, 바람직하기로는 상기 사멸 유산균을 함유하는 발효액을 분쇄기로 분쇄하여 유산균 사체 등의 고형물의 입자가 50㎛ 이하가 되도록 하여 사용하는 것이 바람직하다. 또한, 필요에 따라, 이 발효액을 적당히 농축이나 희석하여 사용할 수도 있으며, 이렇게 얻어진 발효액을 스톡 솔루션(stock solution)으로 하여 1∼5℃의 냉장 보관하면 필요시에 적당히 사용할 수 있다. The obtained lactic acid bacteria and the fermentation broth thereof are heated at 70 to 90 DEG C for 7 to 20 minutes to kill the lactic acid bacteria to stop its activity. Failure to do so may result in the continued propagation of lactic acid bacteria in the final or stock solution, resulting in the failure or destruction of the desired final product quality, and furthermore the product being corrupted. The lactic acid bacteria thus obtained may be used as they are, but it is preferred that the fermentation broth containing the killed lactic acid bacteria be pulverized by means of a pulverizer so that particles of solid matter such as lactic acid germs and the like become 50 탆 or less. If necessary, the fermentation broth can be appropriately concentrated or diluted. The thus obtained fermentation broth can be stored in a stock solution at a temperature of 1 to 5 ° C and used appropriately when necessary.
이렇게 얻어진 유산균 발효액의 배합량은 전체 조성물에 대해 7∼15중량부, 바람직하기로는 8∼12중량부로 하면 좋다. 전술한 함량의 하한치 이하를 배합하면 소양증이나, 피부 트러블의 개선효과가 떨어지고, 상한치 이상을 배합하면, 얻어지는 제품의 전연성, 발림성이 떨어지고, 피부에의 끈적거림이 나타나고, 또한 발효액 특유의 냄새가 강하여 이를 해소하기 위해 강한 향료를 사용하여야 하는 등의 문제점이 있다. The blending amount of the thus-obtained lactic acid fermentation broth may be 7 to 15 parts by weight, preferably 8 to 12 parts by weight, based on the whole composition. When the content is lower than the lower limit of the above-mentioned content, the effect of improving pruritus and skin troubles is deteriorated. If the content is higher than the upper limit value, the resulting product becomes less sticky to the skin and sticky to the skin, There is a problem that a strong fragrance should be used to solve this problem.
본 발명의 유효성분 중의 하나인 플로랄 워터는 저온 임계 추출법으로 추출한 것으로, 통상 꽃수라고도 불린다. 이 플로랄 워터는 라벤더의 잎 및 꽃잎, 병풀(학명: Centella asiatica (L.) Urb.) 잎, 녹차, 카렌듈라 꽃잎을 정제수로 추출한 것이다. 진공추출기로서는 시판의 것을 사용하면 가능하다. 예컨대, 참맥(주)의 진공추출기, 경서기계의 COSMOS-660 등의 초고속 진공 저온(농축)추출기, 초음파 추출기 들를 사용 하면 좋다.As one of the active ingredients of the present invention, the floral water is extracted by the low-temperature critical extraction method and is also commonly referred to as flowering water. This floral water is the leaves and petals of lavender, Centella asiatica (L.) Urb. Leaf, green tea, calendula petals extracted with purified water. A commercially available vacuum extractor can be used. For example, a vacuum extractor of Chamma Corporation, a COSMOS-660 of Kyusyu Machine, an ultrahigh vacuum low temperature (concentrated) extractor, and an ultrasonic extractor may be used.
추출방법은 특히 한정되지 않지만, 세절한 상기 식물의 잎, 꽃잎, 뿌리 등을 증류수에 대해 1:1 내지 1:5의 비율로 혼합하고, 70∼80℃에서 8∼12시간 추출하면 식물 성분이 1∼3중량부를 함유하는 플로랄 워터를 얻을 수 있다. 추출은 각 성분에 대해 각각 추출하여도 좋고, 일시에 혼합하여 추출하여도 좋으나, 각 성분을 각각 추출하여 플로랄 워터를 얻은 후, 이를 스톡 솔루션으로 냉장 보관하는 것이 바람직하다. 또한, 필요에 따라 이를 저온에서 감압, 농축하여 상기에서 얻어진 플로랄 워터 중의 유효성분의 함량을 수분에 대해 30∼50중량%로 함유하도록 농축하여 스톡 솔루션으로 하고, 이를 사용시에 희석하여 5∼10분 동안 약 70∼80℃에서 가온하여 사용하여도 좋다. Although the extraction method is not particularly limited, when the leaves, petals, roots, etc. of the plant are mixed at a ratio of 1: 1 to 1: 5 to distilled water and extracted at 70 to 80 ° C for 8 to 12 hours, 1 to 3 parts by weight of a vegetable oil. The extract may be extracted for each component or may be mixed at one time, but it is preferable to extract each component to obtain a floral water, and then store it in a stock solution. If necessary, it is decompressed and concentrated at a low temperature to concentrate the active ingredient in the obtained floral water to 30 to 50% by weight with respect to water to prepare a stock solution, which is diluted with water for 5 to 10 minutes It may be used by heating at about 70 to 80 占 폚.
또한, 본 발명 조성물의 유효성분 중의 하나인 생약 추출물이란, 유근피 추출물, 병풀 추출물, 청호(제비쑥) 추출물, 님잎 (neem leaf) 추출물, 마치현 추출물을 의미한다. 이들 추출물의 추출방법은 특히 제한되지 않으며, 예를 들면, 종래 통상 사용되어온 방법, 즉, 전술한 진공 저온 농축 추출기 등을 이용하면 좋다. 용매로는 정제수, 에탄올, 글리세린, 이소부틸알코올, 부틸렌글리콜 등의 유기용매 등에서 선택된 1종 또는 2종 이상의 혼합 용매를 이용하여 70∼80℃에서 약 8∼15시간 추출하면 식물 성분이 3∼7중량%를 함유하는 추출액을 얻을 수 있다. 이러한 방법은 진공, 감압하에서 수행하면 상기 온도보다 훨씬 저온에서 단시간에 얻을 수 있음은 당해 분야에 공지이다. Also, the herbal medicine extract which is one of the effective components of the composition of the present invention means a herb extract, a herb extract, a herb extract, a neem leaf extract and a mash extract. The method of extracting these extracts is not particularly limited, and for example, a conventionally used method, that is, the aforementioned vacuum low-temperature thickening extractor may be used. When the solvent is extracted at 70 to 80 ° C for about 8 to 15 hours using one or more mixed solvents selected from water, ethanol, glycerin, isobutyl alcohol, butylene glycol and other organic solvents, 7% by weight of the extract can be obtained. It is known in the art that such a method can be obtained in a short time at a temperature much lower than the above-mentioned temperature under vacuum and reduced pressure.
또한, 필요에 따라 이를 저온에서 감압, 농축하여 상기에서 얻어진 추출액 유효성분의 함량을 수분에 대해 30∼50중량%로 함유하도록 농축하여 스톡 솔루션으로 하고, 이를 사용시에 희석하여 5∼10분 동안 약 70∼80℃에서 가온하여 사용하여도 좋다. If necessary, it is decompressed and concentrated at a low temperature to concentrate the active ingredient in an amount of 30 to 50% by weight based on the total weight of the extract to obtain a stock solution, which is diluted with water for 5 to 10 minutes It may be used by heating at 70 to 80 占 폚.
상기 플로랄 워터 및 생약 추출물 중의 식물 성분들 중, 라벤더꽃은 예로부터 두통, 치통, 생리통 등의 각종 통증, 여드름 치료 등에 효과가 있는 것으로 알려져 있고, 병풀은 상처 치료용 연고제 등의 외용제의 주성분으로 널리 사용되고 있으며, 유근피는 항암효과, 천연 항생제, 만성 비염, 아토피에 치료 효과가 있는 것(국민일보 2013. 6, 10)이 알려져 있고, 청호는 각종 외상, 위염, 혈액순환, 피부질환에 유용함이 한의서 등에 널리 알려져 있으며, 님잎은 천연 비누, 아로마요법 등으로 최근 널리 이용되고 있으며, 감초는 천연 스테로이드를 다량 함유하고 있으며, 기관지 천식, 피부질환, 미백 등으로 한방 약재로 예전부터 널리 알려져 있다. Of the plant ingredients in the floral water and herbal medicine extracts, lavender flowers have been known to be effective for treating various kinds of pain such as headache, toothache, menstrual pain, acne and the like, and it is widely known as a main component of external preparations such as ointment for wound healing It is known that yukchepa has the therapeutic effect on anticancer effect, natural antibiotic, chronic rhinitis and atopy (Kukmin Ilbo 2013, 6, 10), and Chungho is useful for various trauma, gastritis, blood circulation and skin diseases. And is widely used in natural soaps and aromatherapy. Licorice contains a large amount of natural steroids. It is widely known as herbal medicine because of bronchial asthma, skin diseases and whitening.
본 발명에서 상기 플로랄 워터 및 생약 추출물은 각각 25∼45중량%로 배합된다. 이들 성분들의 하한치 이하로 배합하면, 배합에서의 점성이 올라가고, 소양증에 효과가 떨어지고, 피부에의 발림성이 나빠, 피부에 무거운 감이 들며, 상한치 이상을 배합하면 너무 묽어 점도를 조절하는 데 어려움이 있다. In the present invention, each of the floral water and herbal medicine extract is blended in an amount of 25 to 45% by weight. If it is mixed below the lower limit of these components, the viscosity of the formulation increases, the effect on the pruritus deteriorates, the spreadability to the skin becomes worse, and the skin becomes heavy. When the upper limit is exceeded, have.
상기 본 발명의 피부 개선제는 보습 효과를 높이기 위하여 보습제를 배합하는 것이 바람직하다. 보습제로서는 통상 당해 분야에서 사용되는 히아루론산 나트륨과 같은 히아루론산 염, 세라마이드, 카나우바 왁스 등을 배합할 수 있다. 이들의 배합량은 전량에 대해 약 1∼10중량%를 첨가할 수 있다. The skin improving agent of the present invention is preferably blended with a moisturizing agent to improve the moisturizing effect. As the moisturizing agent, hyaluronic acid salts such as sodium hyaluronate, ceramide, carnauba wax and the like which are generally used in the art can be formulated. The blending amount thereof may be about 1 to 10% by weight based on the whole amount.
또한, 점도가 낮은 경우, 점도를 향상시키기 위해 아라비아 검, 잔탄 검, 셀룰로오스 등을 약 0.5 내지 2중량% 정도 첨가하여도 좋다. When the viscosity is low, about 0.5 to 2% by weight of gum arabic, xanthan gum, cellulose or the like may be added to improve the viscosity.
또한, 본 발명의 피부 개선제에 항산화제를 첨가하여 그의 보존 유효기간을 연장시킬 수 있다. 여기서, 항산화제로서는 아스코르브산 또는 그 염, 아스코르브산 에스테르, 에리소르빈산 등이 이용되지만, 아스코르브산 또는 그 염이 특히 바람직하다. 당해 염으로서는 나트륨, 칼륨 등의 알칼리 금속염;칼슘, 마그네슘 등의 알칼리토류 금속염;암모니아염 등을 들 수 있다.In addition, an antioxidant can be added to the skin improving agent of the present invention to prolong the shelf life thereof. As the antioxidant, ascorbic acid or its salt, ascorbic acid ester, erythorbic acid and the like are used, but ascorbic acid or its salt is particularly preferable. Examples of the salt include alkali metal salts such as sodium and potassium; alkaline earth metal salts such as calcium and magnesium; and ammonia salts.
항산화제의 함유량은 전량에 대해 0.01~3중량%가 바람직하다.The content of the antioxidant is preferably from 0.01 to 3% by weight based on the whole amount.
후기 시험예에서 나타내는 바와 같이, 본 발명의 유산균 발효액, 플로랄 워터 및 생약 추출물을 함유하는 피부개선제는 각층 수분량이나 피부 결 스코어가 상승하므로 건조한 피부 상태의 개선제, 즉 피부가 거칠어 지는 것을 예방·개선제로서도 유용하다. 그리고, 아토피성 피부염의 치료 방법의 하나로서 건조한 피부에 대한 보습 등을 행하고, 피부 상태를 개선하는 방법이 있기 때문에도, 당해 피부가 거칠어 지는 것을 예방·개선제는 아토피성 피부염의 치료에 유용하므로, 항알레르기제로서도 사용할 수 있다. 여기서, 「피부가 거칠어 지는 것」이란, 각층 수분량이 감소하여 피부 표면이 건조해지거나 피부 결이 거칠어 지는 것을 말한다.As shown in the later test examples, the skin improving agent containing the lactic acid fermentation broth, the floral water and the herbal extract of the present invention increases the water content and skin score of each layer. Therefore, the agent for improving the dry skin condition, that is, useful. As one of the methods for treating atopic dermatitis, there is a method of moisturizing dry skin and improving the skin condition, so that the agent for preventing or improving skin roughness is useful for the treatment of atopic dermatitis, It can also be used as an anti-allergic agent. Here, " rough skin " means that the water content of each layer decreases and the surface of the skin becomes dry or rough skin becomes rough.
또, 본 발명의 피부개선제는 액상 제제로서 후기에 예를 들었으나, 통상의 연고제로 할 수 있으며, 기타 제형으로 하는 것도 가능하며, 이들 제제에 한정되는 것은 아니다. In addition, although the skin improving agent of the present invention is described later as a liquid preparation, it can be a conventional ointment agent or other formulation, and is not limited to these agents.
본 발명의 피부 알레르기의 예방, 개선제의 제조법에 대하여 이하에 일례를 나타낸다.Hereinafter, an example of the prevention and improvement of the skin allergy of the present invention will be described.
실시예 Example
이하 실시예를 들어 본 발명을 상세히 설명한다. 실시예에서 “부”, “%”눈 특히 언급하지 않는 한, 중량부 및 중량%를 의미한다. Hereinafter, the present invention will be described in detail with reference to examples. Means " parts ", "% ", " parts "
1) 유산균 발효액, 플로랄 워터 및 추출물의 조제:1) Preparation of lactic acid fermentation broth, floral water and extract:
(1) 유산균 발효액의 조제(1) Preparation of lactic acid fermentation broth
현미 뜨물 83g, 다시마 추출물 10g, 유청 파우더 5g, 펩톤 2g 및 센트룸(화이자 제품) 0.5g, 펩톤 2g을 배양 배지로 하고, 여기에 유산균(락토바실루스 박테리아)를 식균하고, 35∼38℃에서 48시간 발효시켜 유산균 발효액을 얻었다. 이를 믹서로 분쇄하여 냉장(약 3℃) 보관하였다. Lactobacillus (lactobacillus bacteria) was inoculated thereinto and cultured at 35 to 38 占 폚 for 48 hours at a temperature of 35 to 38 占 폚, And fermented to obtain a lactic acid fermentation broth. This was ground with a mixer and stored in a refrigerator (about 3 ° C).
(2) 플로랄 워터의 조제 (2) Preparation of floral water
초고속 진공저온추출기(경서기계, COSMOS-660)에 건조 라벤더 꽃과 잎과 증류수를 1:1 중량비로 넣고, 약 70∼80℃에서 8∼12시간 추출하여 라벤더 플로랄 워터를 얻었다. 이 플로랄 워터를 다시 상기 진공 저온추출기에 넣고, 농축하여 라벤더 식물 추출 성분이 30∼50중량%가 되도록 하였다. 이를 방냉하여 냉장(약 3℃) 보관하였다. Lavender floral water was obtained by adding dry lavender flowers, leaves and distilled water at a weight ratio of 1: 1 to a high-speed vacuum low-temperature extracting machine (Kyosho Machine, COSMOS-660) at about 70 to 80 ° C for 8 to 12 hours. This floral water was again added to the vacuum low-temperature extractor and concentrated so that the lavender plant extract component was 30 to 50 wt%. The mixture was allowed to cool and stored at about 3 ° C.
병풀잎, 녹차잎, 카렌듈라 잎을 동일한 방법으로 수행하여 각각의 플로랄 워터를 조제하였다. Bottle grass, green tea leaves, and calendula leaves were prepared in the same manner to prepare each of the floral water.
(3) 추출물의 조제(3) Preparation of extract
초고속 진공저온추출기(경서기계, COSMOS-660)에 건조 병풀을 부틸렌글리콜/에탄올/증류수(50/25/25)의 용매에 1:5의 비율로 넣고, 약 70∼80℃에서 12±3시간 추출하여 병풀 추출물을 얻었다. 얻어진 추출물을 증류하여 유기용매를 회수하였다. 추출물의 농도는 약 5% 정도이었다. 이를 다시 농축하여 추출물 중의 수분을 50% 정도 제거하였다. 이렇게 얻어진 병풀 추출물을 냉장(약 3℃) 보관하였다. In a high-speed vacuum low-temperature extractor (Kyosho Machine, COSMOS-660), the dried plantlets were placed in a solvent of butylene glycol / ethanol / distilled water (50/25/25) at a ratio of 1: 5, The extracts were obtained by extracting time - The obtained extract was distilled and the organic solvent was recovered. The concentration of the extract was about 5%. The extract was concentrated again to remove the water content of the extract by about 50%. The thus-obtained Centella asiatica extract was stored in a refrigerator (about 3 ° C).
청호(제비쑥), 유근피, 마치현, 님잎에 대해서도 동일하게 조제하여 각각의 추출물을 준비하였다. The extracts were prepared in the same manner for each of Chungho (zygoma), yuguni, maji and mysterious leaves.
제조예 1:본 발명의 피부 트러블 개선용 액제의 제조Production Example 1: Preparation of a solution for improving skin trouble of the present invention
상기 유산균 발효액을 10g을 비커에 넣고, 여기에 녹차 플로랄 워터 10g, 라벤더 플로랄 워터 10g, 병풀잎 플로랄 워터 12g 및 카렌듈라 플로랄 워터 8g을 넣고, 약 70℃로 될 때까지 가온하였다. 가온 후, 호모게나이저로 약 10분간 교반하여 균질 액으로 하였다. 10 g of the lactic acid bacteria fermentation broth was placed in a beaker, and 10 g of green tea floral water, 10 g of lavender floral water, 12 g of bottled plant leaf water and 8 g of calendula floral water were added to the beaker and then heated to about 70 캜. After heating, the mixture was homogenized by homogenizer for about 10 minutes.
별도의 비커에 병풀 추출물, 청호 추출물, 님잎 추출물, 유근피 추출물, 마치현 추출물 각각 8g씩 넣고, 이를 80℃까지 가열하였다. 이렇게 얻어진 추출물 혼합액을 상기 유산균 발효액과 플로랄 워터의 혼합액에 넣고, 호모게나이저로 약 10분간 교반하여 균질 액으로 하였다. 8 g of each of the centilla extract, chrysophyllum extract, mulberry leaf extract, root extract, and mashii extract was added to a separate beaker and heated to 80 ° C. The thus obtained extract mixture solution was added to the mixture of the lactic acid fermentation broth and the floral water and stirred for about 10 minutes with a homogenizer to obtain a homogeneous solution.
시험예 1:아토피성 피부염의 억제 시험Test Example 1: Inhibitory test for atopic dermatitis
(1) 개략(1) Outline
아토피성 피부염을 앓고 있는 지원자들을 상대로 1주일간 상기 실시예 1의 액제를 1일 3회 도포하게 하고, 그 결과를 확인하였다. The applicants suffering from atopic dermatitis were allowed to apply the liquid preparation of Example 1 three times a day for one week, and the results were confirmed.
(2) 결과(2) Results
상기 제조예 1의 액제를 도포한 자원자 모두에게서 도포 1일에 소양증이 완전히 없어졌다고 답하였고, 도포 3일 후에는 모두 상당히 개선되었고, 도포 14일 후에는 아토피 증상 거의 제거되고, 소양증은 없어짐을 확인하였다. 이들의 도포 전의 사진과 도포 7일 후의 사진을 도 1 내지 도 7에 나타냈다. All volunteers who applied the liquid preparation of Preparation Example 1 answered that the pruritus completely disappeared on the first day of application and all of them were improved on the 3rd day after application, and after 14 days of application, almost all of the atopic symptoms were removed, Respectively. The photographs before application and those after 7 days of application are shown in Figs. 1 to 7.
이들 도면에서, 도 1 및 도 2는 본 발명의 제조예 1에서 제조한 액제를 심한 소양증을 동반한 아토피성 여드름 증상이 있는 10대 여학생에게 도포하기 전과 도포 3일 및 도포 2주 후의 상태를 나타내는 사진으로서, 도포 3일부터 소양증이 사라지고, 도포 2주에는 여드름성 아토피가 거의 다 사라짐을 나타내고 있다. In these figures, Figs. 1 and 2 show the state of the liquid preparation prepared in Preparation Example 1 of the present invention before application to 10-year-old female students with atopic acne symptoms accompanied by severe pruritus, 3 days after application and 2 weeks after application As a photograph, pruritus has disappeared from the third day of application and almost all of the acne-causing atopy has disappeared in the second week of application.
도 3은 본 발명의 제조예 1에서 제조한 액제를 아토피 증상이 있는 30대 주부의 도포하기 전의 팔 부위와 도포 3일 및 도포 2주 후의 상태를 나타내는 사진으로, 도포 3일째에 아토피가 상당히 개선되었고, 또한 소양증이 사라졌으며, 도포 2주 후에는 아토피가 거의 모두 사라짐을 확인할 수 있다. Fig. 3 is a photograph showing the state of the arm part before application of the 30th housewife with atopic symptoms and the state after 3 days of application and 2 weeks after application of the liquid preparation manufactured in the production example 1 of the present invention. , And pruritus disappeared, and almost all of the atopy disappeared after 2 weeks of application.
도 4는 목 부위에 아토피 증상이 있는 40대 여성의 도포 전과 도포 2주 후의 상태를 나타내는 사진으로, 도포 2주 후에 아토피가 거의 사라짐을 나타낸다. FIG. 4 is a photograph showing the state of a woman in her 40s who has symptoms of atopy on the neck area after application and after 2 weeks of application, showing that atopy almost disappears after 2 weeks of application.
도 5는 손등에 아토피 증상이 있는 30대 남성의 도포 전과 도포 2주 후의 상태를 나타내는 사진으로, 도포 2주 후에 아토피가 거의 다 사라졌음을 나타낸다. FIG. 5 is a photograph showing the state of a male in his thirties with a symptom of atopy in the back of his hand before and 2 weeks after application, showing that atopy almost completely disappeared after two weeks of application.
도 6은 얼굴과 목 부위에 아토피 증상이 있는 30대 여성의 도포 전과 도포 3일 및 도포 2주 후의 상태를 나타내는 사진으로, 우선 도포 3일째에는 소양증이 사라져서 생활에 불편이 없었다고 하며, 도포 2주 후에는 아토피 증상이 거의 사라졌음을 나타낸다. FIG. 6 is a photograph showing the condition of a woman in her thirties with atopic symptoms on the face and neck after 3 days of application and 2 weeks after application. In the first day of application, pruritus disappeared and there was no inconvenience in life. Later, symptoms of atopy almost disappeared.
도 7은 손등과 목 부위에 아토피 증상이 있는 40대 여성의 도포 전과 도포 2주 후의 상태를 나타내는 사진으로, 도포 2주 후에 아토피가 거의 사라졌음을 나타낸다. FIG. 7 is a photograph showing the state of a woman in her 40s who has symptoms of atopy on the back of the hand and neck after 2 weeks of application, showing that atopy almost disappears after 2 weeks of application.
도 8은 종아리 및 무릎 접히는 부분에 아토피 증상이 있는 30대 여성의 도포 전과 도포 3일 후의 상태를 나타내는 사진으로, 도포 3일째에는 소양증이 없어지고, 아토피 증상도 상당히 개선되었음을 나타낸다. FIG. 8 is a photograph showing a state of a woman in her thirties with a symptom of atopy in the calf and a knee folded part before and 3 days after application. In the third day of application, pruritus disappears and atopic symptoms are significantly improved.
Claims (4)
라벤더 꽃잎, 병풀, 녹차, 카렌듈라로 이루어진 식물을 증류수로 추출한 플로랄 워터; 및
유근피, 병풀, 청호, 님잎, 마치현의 추출물을 50 내지 80℃에서 가온한 후, 호모게나이저로 교반하여 얻어진, 피부 트러블의 완화, 개선제.Lactobacillus fermentation broth obtained by using lactobacillus belonging to the genus Lactobacillus, Streptococcus, and Propionibacterium in a medium comprising brown rice, kelp extract and whey;
Floral water extracted from distilled water with plants consisting of lavender petal, cinnabar, green tea, and calendula; And
The present invention relates to a method for alleviating or alleviating skin troubles, which is obtained by warming the extracts of yugi, ciliate, cinnabar, feminized mint leaf, and maji prefecture at 50 to 80 캜 and stirring with a homogenizer.
The relaxation and remedy for skin trouble as claimed in claim 1 or 2, which is obtained by blending 80 to 120 parts by weight of one kind selected from glycerin, hyaluronic acid salt and ceramide against floral water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150117174A KR20170022343A (en) | 2015-08-20 | 2015-08-20 | Prevention, improvement of skin allergy agent based on lactic acid, floral water and medicinal herb extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150117174A KR20170022343A (en) | 2015-08-20 | 2015-08-20 | Prevention, improvement of skin allergy agent based on lactic acid, floral water and medicinal herb extract |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20170022343A true KR20170022343A (en) | 2017-03-02 |
Family
ID=58427280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150117174A Withdrawn KR20170022343A (en) | 2015-08-20 | 2015-08-20 | Prevention, improvement of skin allergy agent based on lactic acid, floral water and medicinal herb extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20170022343A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102026366B1 (en) * | 2018-05-11 | 2019-09-27 | 주식회사 네이처인랩 | Cosmetic composition comprising whey fermented product of complex probiotics, production methode thereof and functional cosmetic composition comprising the same |
KR102129585B1 (en) * | 2019-05-15 | 2020-07-02 | 오가닉브릿지 주식회사 | Composition for improving atopy dermatitis, Atopic dermatitis remedy and Manufacturing method thereof |
KR102142426B1 (en) * | 2020-02-25 | 2020-08-11 | 오가닉브릿지 주식회사 | Cosmetic materials composition for skin-whitening and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof |
KR102160980B1 (en) * | 2020-02-25 | 2020-09-29 | 오가닉브릿지 주식회사 | Cosmetic materials composition for controlling sebum and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof |
KR102160978B1 (en) * | 2020-02-25 | 2020-09-29 | 오가닉브릿지 주식회사 | Cosmetic materials composition for skin trouble care and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof |
KR20200132661A (en) * | 2020-02-06 | 2020-11-25 | 오가닉브릿지 주식회사 | Composition for improving atopy dermatitis, Atopic dermatitis remedy and Manufacturing method thereof |
KR20210104456A (en) * | 2020-02-17 | 2021-08-25 | 오가닉브릿지 주식회사 | Cosmetic materials composition for skin anti-oxidant and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof |
KR102292975B1 (en) * | 2020-02-17 | 2021-08-26 | 오가닉브릿지 주식회사 | Cosmetic materials composition for skin anti-wrinkling and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof |
KR102314359B1 (en) * | 2021-01-08 | 2021-10-20 | 주식회사 더가든오브내추럴솔루션 | A cosmetic composition comprising herb fermentative products as active ingredient, and a preparation method of thereof |
KR20220036055A (en) * | 2020-09-15 | 2022-03-22 | 주식회사 네이처인랩 | A cosmetic composition comprising a fermented product of donkey milk of complex probiotics, a functional cosmetic product including the cosmetic composition, a method for producing the fermented product and a method for producing the cosmetic composition |
CN115414300A (en) * | 2022-10-12 | 2022-12-02 | 广州悦荟化妆品有限公司 | Green tea compound fermentation liquor with effects of resisting oxidation, controlling oil and shrinking pores as well as preparation method and application thereof |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10076A (en) | 1853-10-04 | Cookibtg-ralsrae | ||
US10081A (en) | 1853-10-04 | Air-engine | ||
US10110A (en) | 1853-10-11 | Improvement in cob and stalk cutters | ||
US10112A (en) | 1853-10-11 | Stbaw-cutter | ||
US10104A (en) | 1853-10-11 | Ash-pah for locomotive-engines | ||
US10141A (en) | 1853-10-18 | Improved life-preserving seat | ||
US10125A (en) | 1853-10-18 | Sofa-bed | ||
US10127A (en) | 1853-10-18 | Attaching artificial teeth to the metallic plate | ||
US10144A (en) | 1853-10-18 | Door-lock | ||
JP2000139406A (en) | 1998-09-11 | 2000-05-23 | Sunstar Inc | Antiallergic agent and anti-itching agent |
WO2003016544A1 (en) | 2001-08-10 | 2003-02-27 | Meiji Dairies Corporation | Process for producing 1,4-dihydroxy-2-naphthoic acid |
KR100431076B1 (en) | 2003-06-16 | 2004-05-12 | 주식회사 코스메카코리아 | A cosmetic composition containing the mixture of natural plant extracts to recover atopy skin |
KR100875075B1 (en) | 2008-05-01 | 2008-12-18 | 하호원 | Plant extract composition for skin pruritus relief |
KR100906386B1 (en) | 2009-03-17 | 2009-07-07 | 이동우 | Insulating fabric and its manufacturing method |
KR20100126285A (en) | 2008-02-29 | 2010-12-01 | 메이지 데어리즈 코포레이션 | Anti-allergic agent |
KR101013061B1 (en) | 2008-07-08 | 2011-02-14 | 한림대학교 산학협력단 | Alcoholic extract of Yellow Cordyceps sinensis for the prevention and treatment of skin pruritus and atopic dermatitis |
KR101068375B1 (en) | 2010-03-05 | 2011-09-28 | 장흥군청 | Composition for the treatment of atopic dermatitis containing extracts of Saenghwanghwang, Seokchangpo, Red ginseng, Korean vinegar, and yellowish white as active ingredients |
KR101087572B1 (en) | 2010-02-04 | 2011-11-28 | 참살이 모악골 영농조합법인 | Compositions for the Prevention or Treatment of Atopic Dermatitis |
KR101226758B1 (en) | 2010-09-28 | 2013-01-25 | 한국 한의학 연구원 | Composition for Prevention or Treatment of Atopic Dermatitis Comprising Herbal Extract and Fermentation Product thereof with Lactic acid Bacteria |
KR101252107B1 (en) | 2010-10-15 | 2013-04-12 | 이정복 | Composition for the prevention or treatment of atopic dermatitis containing herbal medicines |
KR101262813B1 (en) | 2009-12-15 | 2013-05-09 | 서정희 | The composition comprising picrasma quassioides extract for preventing and treating atopic dermatitis or allergic skin diseases |
-
2015
- 2015-08-20 KR KR1020150117174A patent/KR20170022343A/en not_active Withdrawn
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10076A (en) | 1853-10-04 | Cookibtg-ralsrae | ||
US10081A (en) | 1853-10-04 | Air-engine | ||
US10110A (en) | 1853-10-11 | Improvement in cob and stalk cutters | ||
US10112A (en) | 1853-10-11 | Stbaw-cutter | ||
US10104A (en) | 1853-10-11 | Ash-pah for locomotive-engines | ||
US10141A (en) | 1853-10-18 | Improved life-preserving seat | ||
US10125A (en) | 1853-10-18 | Sofa-bed | ||
US10127A (en) | 1853-10-18 | Attaching artificial teeth to the metallic plate | ||
US10144A (en) | 1853-10-18 | Door-lock | ||
JP2000139406A (en) | 1998-09-11 | 2000-05-23 | Sunstar Inc | Antiallergic agent and anti-itching agent |
WO2003016544A1 (en) | 2001-08-10 | 2003-02-27 | Meiji Dairies Corporation | Process for producing 1,4-dihydroxy-2-naphthoic acid |
KR100431076B1 (en) | 2003-06-16 | 2004-05-12 | 주식회사 코스메카코리아 | A cosmetic composition containing the mixture of natural plant extracts to recover atopy skin |
KR20100126285A (en) | 2008-02-29 | 2010-12-01 | 메이지 데어리즈 코포레이션 | Anti-allergic agent |
KR100875075B1 (en) | 2008-05-01 | 2008-12-18 | 하호원 | Plant extract composition for skin pruritus relief |
KR101013061B1 (en) | 2008-07-08 | 2011-02-14 | 한림대학교 산학협력단 | Alcoholic extract of Yellow Cordyceps sinensis for the prevention and treatment of skin pruritus and atopic dermatitis |
KR100906386B1 (en) | 2009-03-17 | 2009-07-07 | 이동우 | Insulating fabric and its manufacturing method |
KR101262813B1 (en) | 2009-12-15 | 2013-05-09 | 서정희 | The composition comprising picrasma quassioides extract for preventing and treating atopic dermatitis or allergic skin diseases |
KR101087572B1 (en) | 2010-02-04 | 2011-11-28 | 참살이 모악골 영농조합법인 | Compositions for the Prevention or Treatment of Atopic Dermatitis |
KR101068375B1 (en) | 2010-03-05 | 2011-09-28 | 장흥군청 | Composition for the treatment of atopic dermatitis containing extracts of Saenghwanghwang, Seokchangpo, Red ginseng, Korean vinegar, and yellowish white as active ingredients |
KR101226758B1 (en) | 2010-09-28 | 2013-01-25 | 한국 한의학 연구원 | Composition for Prevention or Treatment of Atopic Dermatitis Comprising Herbal Extract and Fermentation Product thereof with Lactic acid Bacteria |
KR101252107B1 (en) | 2010-10-15 | 2013-04-12 | 이정복 | Composition for the prevention or treatment of atopic dermatitis containing herbal medicines |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102026366B1 (en) * | 2018-05-11 | 2019-09-27 | 주식회사 네이처인랩 | Cosmetic composition comprising whey fermented product of complex probiotics, production methode thereof and functional cosmetic composition comprising the same |
KR102129585B1 (en) * | 2019-05-15 | 2020-07-02 | 오가닉브릿지 주식회사 | Composition for improving atopy dermatitis, Atopic dermatitis remedy and Manufacturing method thereof |
CN113825494B (en) * | 2019-05-15 | 2023-09-01 | 有机桥股份有限公司 | Atopic dermatitis improving agent composition, atopic dermatitis improving agent and method for producing the same |
CN113825494A (en) * | 2019-05-15 | 2021-12-21 | 有机桥股份有限公司 | Atopic dermatitis improving agent composition, atopic dermatitis improving agent, and method for producing same |
WO2020230981A3 (en) * | 2019-05-15 | 2021-04-29 | 오가닉브릿지 주식회사 | Atopic dermatitis alleviating agent composition, atopic dermatitis alleviating agent, and preparation method therefor |
KR20200132661A (en) * | 2020-02-06 | 2020-11-25 | 오가닉브릿지 주식회사 | Composition for improving atopy dermatitis, Atopic dermatitis remedy and Manufacturing method thereof |
KR102292975B1 (en) * | 2020-02-17 | 2021-08-26 | 오가닉브릿지 주식회사 | Cosmetic materials composition for skin anti-wrinkling and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof |
KR20210104456A (en) * | 2020-02-17 | 2021-08-25 | 오가닉브릿지 주식회사 | Cosmetic materials composition for skin anti-oxidant and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof |
KR102160980B1 (en) * | 2020-02-25 | 2020-09-29 | 오가닉브릿지 주식회사 | Cosmetic materials composition for controlling sebum and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof |
KR102160978B1 (en) * | 2020-02-25 | 2020-09-29 | 오가닉브릿지 주식회사 | Cosmetic materials composition for skin trouble care and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof |
KR102142426B1 (en) * | 2020-02-25 | 2020-08-11 | 오가닉브릿지 주식회사 | Cosmetic materials composition for skin-whitening and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof |
KR20220036055A (en) * | 2020-09-15 | 2022-03-22 | 주식회사 네이처인랩 | A cosmetic composition comprising a fermented product of donkey milk of complex probiotics, a functional cosmetic product including the cosmetic composition, a method for producing the fermented product and a method for producing the cosmetic composition |
KR102314359B1 (en) * | 2021-01-08 | 2021-10-20 | 주식회사 더가든오브내추럴솔루션 | A cosmetic composition comprising herb fermentative products as active ingredient, and a preparation method of thereof |
CN115414300A (en) * | 2022-10-12 | 2022-12-02 | 广州悦荟化妆品有限公司 | Green tea compound fermentation liquor with effects of resisting oxidation, controlling oil and shrinking pores as well as preparation method and application thereof |
CN115414300B (en) * | 2022-10-12 | 2023-10-17 | 广州悦荟化妆品有限公司 | Green tea composite fermentation liquor with effects of resisting oxidation, controlling oil and shrinking pores and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20170022343A (en) | Prevention, improvement of skin allergy agent based on lactic acid, floral water and medicinal herb extract | |
CN110585114B (en) | Bactericidal composition for regulating skin microbial flora and application thereof | |
JP2018520985A (en) | Antibacterial Chinese medicine composition, method for producing the same | |
KR101862568B1 (en) | Composition for Prevention or Improving of Atopic Dermatitis Comprising Herbal Fermentation Product with microorganism | |
WO2021179567A1 (en) | Chinese mugwort leaf composite essential oil for relieving sore throat and preparation method therefor | |
KR20080079743A (en) | Method of manufacturing fermented products using wild grasses having a therapeutic effect on atopic dermatitis | |
KR20210017590A (en) | Cosmetic composition comprising fermented vegetable oil and fermented vegetable extract | |
JPH06279256A (en) | Skin external preparation | |
CN109329319B (en) | Preparation method of traditional Chinese medicine fermented mosquito repellent liquid, stock solution and diluent thereof | |
CN111888306A (en) | Essence for removing blackheads and repairing rosacea and preparation method thereof | |
CN109260054B (en) | Plant anti-mosquito itching-relieving cream and preparation method thereof | |
KR20160002093A (en) | Cosmetic composition for skin diseases or disorders | |
KR20130135223A (en) | Cosmetic composition for preventing of kin trouble | |
KR101585922B1 (en) | Preparation method for natural shampoo composition comprising plant extracts and natural surfactant | |
CN108451889A (en) | A kind of probiotics antiallergy repair cream | |
KR101354412B1 (en) | Cosmetic composition for improving atopic dermatitis and skin whitening comprising ferment filtrate of Ledum palustre var. diversipilosum and manufacturing method thereof | |
US20220047494A1 (en) | Antibacterial, deodorization, easing of acne and atopy or skin calming-functional composition for y-zone cleanliness containing quercus acutissima sap and zinc ricinoleate | |
KR20140141080A (en) | Composition containing extract using process of herbal medicine | |
KR101681258B1 (en) | Natural shampoo composition comprising plant extracts and natural surfactant | |
KR20160012514A (en) | Anti-inflammatory cosmetic composition comprising Artemisia princeps Leaf fermentation extracts | |
CN115364002B (en) | Foundation liquid with acne removing effect and preparation method thereof | |
KR101479550B1 (en) | Cosmetics composition containing germinated Phaseolus radiatus, germinated Phaseolus angularis and extracts of Sophora flavescens | |
KR20140011746A (en) | Composition for alleviating atopic dermatitis comprising mineral including microorganism and natural enzyme | |
CN113616801A (en) | Preparation method and application of antiseptic and antibacterial preparation containing Scutellariae radix extract | |
KR101363028B1 (en) | A cosmetic composition for the prevention, improvement or treatment of acne vulgaris comprising the mixture of extract of Melissa officinalis, Citrus bergamia, leaves of Mentha arvensis, Eclipta prostrata and Hovenia dulcis Thunb |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20150820 |
|
PG1501 | Laying open of application | ||
PC1203 | Withdrawal of no request for examination |